期刊
ONCOGENE
卷 26, 期 10, 页码 1492-1498出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1209905
关键词
human ovarian surface epithelial cells; immortalization; siRNA; pRb; hTERT
资金
- NCI NIH HHS [CA016672] Funding Source: Medline
The risk of developing ovarian cancer is about 1% over a lifetime, but it is the most deadly gynecologic cancer, in part due to lack of diagnostic markers for early-stage disease and cell model system for studying early neoplastic changes. Most existing immortal human ovarian surface epithelial cells were achieved by using viral protein such as SV40 T/t antigen or E6/E7, which inactivate multiple cellular pathways. In the current study, we used a small interfering RNA ( siRNA) against the retinoblastoma gene (pRb) and ectopic expression of human telomerase reverse transcriptase ( hTERT) to immortalize the primary ovarian epithelial cell line OSE137 and two additional human ovarian surface epithelial cells. The immortalized OSE137 showed increased telomerase activity, lengthened telomeres, increased G(2)/M phase, altered cell-cycle regulatory proteins but nontumorigenic. As both Rb and hTERT pathways are commonly altered in human ovarian cancer and these genetic changes are faithfully modeled in these cells without using viral protein, these immortal cells represent an authentic in vitro model system with which to study the initiation and progression of human ovarian cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据